Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis

Nephrology Dialysis Transplantation

Volumn 24, Issue 1, 2009, Pages 231-238

  Churchwell, Mariann D ^a,b   Pasko, Deborah A ^b   Smoyer, William E ^b,c   Mueller, Bruce A ^b,d  

^a UNIVERSITY OF TOLEDO   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Albumin dialysate; Carbamazepine; CVVHD; Phenytoin; Valproic acid

Indexed keywords

ALBUMIN; CARBAMAZEPINE; PHENYTOIN; POLYSULFONE; VALPROIC ACID;

ARTICLE; BLOOD FLOW; DIALYSATE; DRUG BLOOD LEVEL; DRUG CLEARANCE; EXPERIMENTAL MODEL; HEMODIALYSIS; IN VITRO STUDY; PRIORITY JOURNAL;

ALBUMINS; ANIMALS; CARBAMAZEPINE; CATTLE; DRUG TOXICITY; HEMODIALYSIS SOLUTIONS; HUMANS; MODELS, BIOLOGICAL; PHENYTOIN; POISONING; PROTEIN BINDING; RENAL DIALYSIS; VALPROIC ACID;

EID: 58049220328     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn467     Document Type: Article

References (36)

1. Bronstein AC, Spyker DA, Cantilena LR et al. 2006 Annual Report of the American Association of Poison Control Centers' National Poisoning and Exposure Data System (NPDS). Clin Toxicol 2007; 45: 815-917
2. Winchester JF, Boldur A, Oleru C et al. Use of dialysis and hemoperfusion in treatment of poisoning. In: Daugirdas JT et al. (eds). Handbook of Dialysis, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2007, 300-322
3. Nitsche V, Mascher H. The pharmacokinetics of valproic acid after oral and parenteral administration in healthy volunteers. Epilepsia 1982; 2: 153-162
4. Franssen EJ, van Essen GG, Portman AT et al. Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion. Ther Drug Monit 1999; 3: 289-292
5. Hicks LK, McFarlane PA. Valproic acid overdose and haemodialysis. Nephrol Dial Transplant 2001; 16: 1483-1486
6. Kane SL, Constantiner M, Staubus AE et al. High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose. Ann Pharmacother 2000; 34: 1146-1151
7. Minari M, Maggiore U, Tagliavini D et al. Severe acute valproic acid intoxication successfully treated with hemodiafiltration without hemoperfusion. Ann Emerg Med 2002; 39: 204-205
8. Singh SM, McCormick BB, Mustata S et al. Extracorporeal management of valproic acid overdose: a large regional experience. J Nephrol 2004; 17: 43-49
9. Rawlins MD, Collste P, Bertilsson L et al. Distribution and elimination kinetics of carbamazepine in man. Eur J Clin Pharmacol 1975; 8: 91-96
10. Lee CS, Wang LH, Marbury TC et al. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis. Clin Toxicol 1980; 17: 429-438
11. Schuerer DJ, Brophy P, Bunchman T et al. High-efficiency dialysis for carbamazepine overdose. J Toxicol Clin Toxicol 2000; 38: 321-323
12. Kielstein JT, Schwarz A, Arnavaz A et al. High-flux hemodialysis - an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol 2002; 57: 484-486
13. Unei H, Ikeda H, Murakami T et al. Detoxication treatment for carbamazepine and lithium overdose. Yakugaku Zasshi 2008; 128: 165-170
14. Shalkham AS, Kirrane BM, Hoffman RS et al. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis 2006; 48: 239-241
15. Boobis SW. Alteration of plasma albumin in relation to decreased drug binding in uremia. Clin Pharmacol Ther 1977; 22: 147-153
16. Brenchie D, Bastani B. Significant removal of phenytoin during high flux dialysis with cellulose triacetate dialyzer (letter). Nephrol Dial Transplant 1998; 13: 817
17. De Schoenmakere G, De Waele J, Terryn W et al. Phenytoin intoxication in critically ill patients. Am J Kidney Dis 2005; 45: 189-192
18. Kawasaki C, Nishi R, Uekihara S et al. Charcoal hemoperfusion in the treatment of phenytoin overdose. Am J Kidney Dis 2000; 35: 323-326
19. Churchwell MD, Pasko DA, Mueller BA. Daptomycin clearance during modeled continuous renal replacement therapy. Blood Purif 2006; 24: 548-554
20. Clark WR, Macias WL, Molitoris BA et al. Membrane adsorption of beta 2-microglobulin: equilibrium and kinetic characterization. Kidney Int 1994; 46: 1140-1146
21. Churchwell MD, Pasko DA, Btaiche IF et al. Trace element removal during in vitro and in vivo continuous hemodialysis. Nephrol Dial Transplant 2007; 22: 2970-2977
22. Mitzner SR, Stange J, Klammt S et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-286
23. Seige M, Kreymann B, Jeschke B et al. Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis. Transplant Proc 1999; 31: 1371
24. Patzer J. Principles of bound solute dialysis. Ther Apher Dial 2006; 10: 118-124
25. Sen S, Ytrebo LM, Rose C et al. Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs. Int Care Med 2004; 30: 496-501
26. Awad SS, Swaniker F, Magee J et al. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001; 130: 354-362
27. Chawla LS, Georgescu F, Abell B et al. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serumbilirubin. Am J Kidney Dis 2005; 45:e51-e56
28. Kreymann B, Seige M, Schweigart U et al. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999; 31: 1080-1085
29. Diez GR, Grelon G, Gadano A et al. Combined extended haemodialysis with single-pass albumin dialysis (SPAED). Nephrol Dial Transplant 2007; 22: 2731-2732
30. Sauer IM, Goetz M, Steffen I et al. In vitro comparison of the molecular adsorbent recirculation system (MARS) and singlepass albumin dialysis (SPAD). Hepatology 2004; 39: 1408-1414
31. Sen S, Felldin M, Steiner C et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease. Liver Transpl 2002; 8: 962-967
32. Askenazi DJ, Goldstein SL, Chang I et al. Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis. Pediatrics 2004; 113: 406-409
33. Pasko DA, Grio M, Thomas S et al. Methotrexate transmembrane clearance during albumin based continuous venovenous hemodialysis. Blood Purif 2005; 23: 165
34. Sen S, Ratnaraj N, Davies NA et al. Treatment of phenytoin toxicity by the molecular adsorbent recirculating system (MARS). Epilepsia 2003; 44: 265-267
35. Patzer JF, Bane SE. Bound solute dialysis. ASAIO J 2003; 49: 271-281
36. Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif 1998; 16: 261-268